Loading…
Loading…
HART (NYLI Healthy Hearts ETF) is no longer actively trading.
This usually means the fund has been liquidated, merged into another product, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
Data indicate that inflation is easing. Add to that, the Inflation Reduction Act, which passed last year, allows Medicare to negotiate prices on some popular drugs with pharmaceutical companies.
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
The healthcare sector, the second-largest sector allocation in the S&P 500, performed significantly less poorly than the broader market in 2022 and that relative sturdiness has some market observers optimistic about the group's 2023 prospects.
With just two trading days left in 2022, it's safe to say the healthcare sector was significantly less bad than the broader market. As of December 27, the S&P 500 Health Care Index was down just 2.2% year-to-date compared to nearly 19% for the S&P 500.
With compelling long-term opportunities available across multiple industry groups, healthcare has the makings of a 2023 redemption, potentially boding well for exchange traded funds such as the IQ Healthy Hearts ETF (HART).
The defensive healthcare sector is living up to its billing this year, as the S&P 500 Health Care Index is lower by just 0.72% compared to 15.37% for the S&P 500.
On the surface, healthcare appears to be a sector with obvious environmental, social, and governance (ESG) credentials, meaning it's not surprising the group is prominent in an array of ESG exchange traded funds. However, healthcare isn't “ESG perfect.
Experienced healthcare investors know that the Food & Drug Administration (FDA) often looms large. After all, that is the regulatory body that has the final say in whether or not biotechnology and pharmaceutical companies can bring drugs to market.
SEC filings for HART aren't indexed yet — common for recently launched funds. Browse the issuer's filings on SEC EDGAR directly.